Viewing Study NCT00036556


Ignite Creation Date: 2025-12-24 @ 11:37 PM
Ignite Modification Date: 2026-03-08 @ 11:26 PM
Study NCT ID: NCT00036556
Status: COMPLETED
Last Update Posted: 2007-08-15
First Post: 2002-05-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer
Sponsor: Abbott
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostatic Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hormone-Refractory Prostate Cancer View